Explore 3 Stock Ideas & Industry Insights Download Free Report

News

Ocular Therapeutix Files Q3 2026 Report: 220M Shares Outstanding

Ocular Therapeutix, Inc. (NASDAQ:OCUL) submitted its quarterly report on Form 10-Q for the period ended September 30, 2026, disclosing share count, pipeline status, and financial statement structure for the third quarter of its fiscal year.

Aakashdeep | 09 November 2026

FACT II Plans Non-Redemption Deals Ahead of Nov. 17 Meeting

FACT II Acquisition Corp. filed a Form 8-K on November 9, 2026, disclosing plans to enter into non-redemption agreements with unaffiliated investors ahead of an extraordinary general meeting scheduled for November 17, 2026, and reporting a trust account redemption price of approximately $10.81 per …

Vinay Lochav | 09 November 2026

Powerfleet Reports Fiscal Q2 2027 Results on Nov. 9

Powerfleet, Inc. filed a Form 8-K with the SEC on November 9, 2026, furnishing a press release and slide presentation covering financial results for the fiscal quarter ended September 30, 2026.

Vinay Lochav | 09 November 2026

Zura Bio Issues TibuSHIELD Phase 2 Clinical Update for ZB-106

Zura Bio Limited filed a Form 8-K on November 9, 2026, disclosing a clinical update on its Phase 2 TibuSHIELD study of tibulizumab (ZB-106) in adults with moderate-to-severe hidradenitis suppurativa.

Aditi Sarkar | 09 November 2026

Aura Biosciences Reports Q3 2026 Financial Results

Aura Biosciences, Inc. filed a Current Report on Form 8-K with the SEC on November 9, 2026, announcing its financial results for the quarter ended September 30, 2026, and an updated corporate presentation.

Aakashdeep | 09 November 2026

AMG Reports Q3 2026 Results, Declares $0.01 Dividend

Affiliated Managers Group, Inc. filed a Form 8-K on November 9, 2026, disclosing its financial and operating results for the quarter ended September 30, 2026, and announcing a quarterly common stock dividend of $0.01 per share.

Aditi Sarkar | 09 November 2026

Akamai Amends Credit Deal, Plans $2.2B Convertible Notes

Akamai Technologies, Inc. filed an 8-K on November 9, 2026, disclosing a November 5, 2026 amendment to its Credit Agreement and announcing an intended private offering of $2.2 billion in Convertible Senior Notes.

Aakashdeep | 09 November 2026

Scott Sherman Gets 54,926 RSUs and PSUs at Sally Beauty

Scott C. Sherman, SVP, CLO and CHRO of Sally Beauty Holdings, Inc., filed a Form 4 on November 9, 2026, disclosing five derivative security acquisitions dated November 4, 2026, covering newly awarded restricted stock units and certified performance stock units.

Manish Choudhary | 09 November 2026

Keurig Dr Pepper Q3 2026: Net Sales Rise to $7.34B

Keurig Dr Pepper Inc. filed its Form 10-Q for the quarterly period ended September 30, 2026, with the SEC on November 9, 2026, reporting third-quarter net sales of $7,344 million and net income attributable to KDP of $882 million.

Anjali Anand | 09 November 2026

Mark Gregory Spinks Acquires RSUs and PSUs at Sally Beauty

A Form 4 filed with the SEC on November 9, 2026, discloses that Mark Gregory Spinks, President of Beauty Systems Group at Sally Beauty Holdings, Inc. (NYSE:SBH), acquired five tranches of restricted stock units and performance stock units on November 4, 2026.

Manish Choudhary | 09 November 2026
Support

Hi! How can we help you today?

Loading…